SHAP MEDICAL PRACTICE — All Prescriptions & Medications — Page 5
Practice Code: A82031 | PENRITH, CA10 3LW
Showing results 201-250 of 459
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Calcipotriol | 56 | 4,020 | £1.8K | -67.1% ▼ |
| Tiotropium bromide | 55 | 751 | £1.3K | -81.9% ▼ |
| Dorzolamide and timolol | 55 | 1,655 | £798 | -61.6% ▼ |
| 54 | 3,450 | £293 | -22.6% ▼ | |
| Insulin degludec | 53 | 221 | £2.4K | -51.8% ▼ |
| Flecainide acetate | 52 | 3,088 | £103 | -33.4% ▼ |
| Reboxetine | 52 | 1,092 | £306 | +237.6% ▲ |
| Trihexyphenidyl hydrochloride | 52 | 364 | £18 | +83.4% ▲ |
| Quinine sulfate | 51 | 1,428 | £260 | -82.4% ▼ |
| Colchicine | 51 | 1,776 | £35 | -34.6% ▼ |
| Zopiclone | 50 | 726 | £31 | -91.0% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 50 | 4,484 | £308 | -77.9% ▼ |
| Fluconazole | 50 | 405 | £90 | -35.3% ▼ |
| Dexamethasone | 50 | 255 | £149 | -70.9% ▼ |
| Trazodone hydrochloride | 49 | 1,723 | £60 | -76.0% ▼ |
| Paroxetine hydrochloride | 49 | 1,480 | £77 | -73.7% ▼ |
| Glimepiride | 49 | 1,450 | £42 | -46.9% ▼ |
| Alfuzosin hydrochloride | 49 | 2,372 | £468 | -31.5% ▼ |
| 49 | 8,190 | £243 | -82.3% ▼ | |
| 49 | 49 | £224 | -4.5% ▼ | |
| Fluticasone/umeclidinium/vilanterol | 48 | 48 | £1.9K | -79.5% ▼ |
| Co-amoxiclav (Amoxicillin/clavulanic acid) | 48 | 1,216 | £126 | -68.6% ▼ |
| Biphasic isophane insulin | 48 | 260 | £1.0K | -57.0% ▼ |
| Methotrexate | 48 | 192 | £2.6K | +61.0% ▲ |
| Other multivitamin preparations | 48 | 1,776 | £544 | -72.2% ▼ |
| Sodium bicarbonate | 47 | 4,744 | £237 | -49.1% ▼ |
| 47 | 370 | £134 | -77.5% ▼ | |
| Terbinafine hydrochloride | 46 | 1,288 | £362 | -25.6% ▼ |
| Fluticasone furoate | 46 | 46 | £318 | -76.3% ▼ |
| 46 | 510 | £63 | +22.3% ▲ | |
| Carbimazole | 45 | 1,918 | £75 | -60.2% ▼ |
| 45 | 1,352 | £221 | +34.8% ▲ | |
| Fluticasone propionate (Nasal) | 44 | 159 | £535 | -69.8% ▼ |
| Biphasic insulin lispro | 43 | 460 | £2.5K | +0.2% vs avg |
| Diclofenac diethyl | 43 | 4,040 | £282 | -87.9% ▼ |
| 43 | 323 | £313 | +38.1% ▲ | |
| Olmesartan medoxomil | 42 | 1,176 | £45 | -39.0% ▼ |
| Dulaglutide | 42 | 136 | £2.3K | -63.4% ▼ |
| 41 | 778 | £400 | -17.0% ▼ | |
| 41 | 7,040 | £368 | -59.6% ▼ | |
| Ticagrelor | 40 | 1,757 | £1.5K | -53.0% ▼ |
| Buprenorphine | 40 | 1,120 | £630 | -89.1% ▼ |
| Risedronate sodium | 40 | 160 | £46 | -67.0% ▼ |
| Valsartan | 39 | 1,092 | £296 | -33.8% ▼ |
| Terbutaline sulphate | 39 | 48 | £354 | -28.1% ▼ |
| Nystatin | 39 | 1,170 | £63 | -61.3% ▼ |
| Magnesium glycerophosphate | 39 | 2,984 | £1.9K | +183.8% ▲ |
| 39 | 5,228 | £336 | -91.8% ▼ | |
| Pancreatin | 38 | 17.2K | £4.3K | -65.8% ▼ |
| Nebivolol | 38 | 1,904 | £377 | -64.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.